Biosimilar Market is Projected to Reach USD 185.1 Billion by 2033 | At CAGR 24.1%
Overview of the Biosimilar Market: The biosimilar market refers to biologic medical products that are highly similar to already approved reference biologics in terms of safety, purity, and efficacy. Biosimilars are playing a crucial role in expanding access to advanced therapies while reducing healthcare costs. They are widely used in treating chronic diseases such as cancer, autoimmune...
0 Commentarios 0 Compartido 52 Vistas